Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03689920 · ClinicalTrials.gov registry record · NA
Combining Mechanisms for Better Outcomes (COMBO)
A NA study, sponsored by Boston Scientific Corporation.
- Completed
- Registry status
- NA
- Development phase
- 174
- Enrollment target
NCT03689920 is a NA study that has completed, run by Boston Scientific Corporation. The registered enrollment target is 174 participants.
The verdict
NCT03689920, a NA study, has completed, sponsored by Boston Scientific Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 174 participants
- Enrollment target
Study Summary
To evaluate the effectiveness of Spinal Cord Stimulation (SCS) with multiple modalities as compared to conventional SCS in patients with chronic pain when using the Boston Scientific Spectra WaveWriter SCS System.
Interventions
- DEVICE Boston Scientific Spectra WaveWriter™ Spinal Cord Stimulation (SCS) System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 174 participants |
| Start Date | 2018-10-03 |
| Est. Completion | 2021-12-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03689920
The ClinicalTrials.gov registry entry for NCT03689920 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 174 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Scientific Corporation, which has 280 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Boston Scientific Spectra WaveWriter™ Spinal Cord Stimulation (SCS) System is the first listed.
NCT03689920 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03689920 about?
NCT03689920 is a clinical study titled "Combining Mechanisms for Better Outcomes (COMBO)". To evaluate the effectiveness of Spinal Cord Stimulation (SCS) with multiple modalities as compared to conventional SCS in patients with chronic pain when using the Boston Scientific Spectra WaveWriter SCS System.
What is the current status of trial NCT03689920?
This trial is currently completed. It is a NA study. The enrollment target is 174 participants. The study started on 2018-10-03. Estimated completion is 2021-12-15.
What interventions are being tested in trial NCT03689920?
The interventions under investigation include: Boston Scientific Spectra WaveWriter™ Spinal Cord Stimulation (SCS) System (DEVICE).
Who is sponsoring clinical trial NCT03689920?
This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.